1 2 The Good, Bad, Ugly and Deadly.

Slides:



Advertisements
Similar presentations
REVIEW OF AHA DIETARY GUIDELINES Nita Purcell, MS, RD, LD, CDE.
Advertisements

Lipoprotein Metabolism And Disorders
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Mosby items and derived items © 2006 by Mosby, Inc. Slide 1 Chapter 19 Coronary Heart Disease and Hypertension.
Lipid Profile.

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.
Lipids (Lipid Profile)
Cholesterol. CHOLESTEROL What is it? How does it cause heart disease? A fat like substance in your blood When there is too much cholesterol in your blood,
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
MI: Risk Factors and Primary Prevention. Risk Factors Factors that appear to increase the general population’s chances of experiencing a health problem.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Hyperlipidemia Chapter 22. VIDEO There are four principal lipoprotein classes:lipoprotein 1. Chylomicrons are derived from intestinal absorption of exogenous.
Lipoproteins Clusters of lipids associated with proteins that serve as transport vehicles for lipids in the lymph and blood.
Cholesterol.
Nutrition and Cardiovascular Disease. Cardiovascular Disease Includes heart attack, stroke Includes heart attack, stroke Leading cause of death in the.
Cholesterol is among the lipids (fats) in the bloodstream. Source: Supplied from diet or synthesized by liver. Importance: 1.Form cell membranes and.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Lab. 8.  The major lipids present in the plasma are:  fatty acids,  Triglycerides,  cholesterol  and phospholipids.  Other lipid-soluble substances,
Determination of triglyceride in serum Dept.of Biochemistry.
 Main lipids in the blood are the triglycerides and cholesterol.  Insoluble in the water.  Transport in the blood is via lipoproteins.
Triglyceride Estimation
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
CVD Epidemiology Case Studies Nathan D. Wong PhD, FACC, Associate Professor and Director, Heart Disease Prevention Program, University of California, Irvine.
An aortic aneurysm can rupture (dissecting aneurysm) and cause massive blood loss, circulatory shock and rapid death.
Part 2 Lipids & Lipoproteins. Lipid and Lipoprotein Population Distributions Serum lipoprotein concentrations differ between adult men and women, Primarily.
LIPID describes a chemically varied group of fatty substances and are highly concentrated energy stores. They are water-insoluble bio-molecules but soluble.
TOTAL CHOLESTEROL It is generally agreed that the normal range for total cholesterol is rather wide. Serum total cholesterol is slightly higher in men.
Triglycerides The major lipids of the body (triglycerides, cholesterol, phospholipids and glycolipids) play a variety of biologic roles. They serve as:
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Outline of Today’s lecture 1. Introduction of Triglyceride 2. Clinical significance of Triglyceride 3. Principle of Triglyceride estimation.
Lab (6): Lipids profile KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012 T.A Nouf Alshareef
Outline of Today’s lecture 1. Discuss the different types of cholesterol 2. Identify healthy cholesterol levels 3. Clinical significance of cholesterol.
LIPID describes a chemically varied group of fatty substances and are highly concentrated energy stores. They are water-insoluble bio-molecules but soluble.
The presence of cardiovascular disease is an important predictor of mortality in patients with end-stage renal disease, as it accounts for almost 50 percent.
Chapter 09 9 Hyperlipidemia and Dyslipidemia C H A P T E R Grandjean, Gordon, Davis, and Durstine.
Lipids profile.
Triglyceride determination
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Serum Cholesterol Presented By Assist.Lecturer Aseel Ghassan Daoud
Practical Analysis Using Spectrophotometer
Cholesterol practice questions
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Basic laboratory testing
National Cholesterol Education Program
Basic laboratory testing
Classification of total cholesterol levels
Diabetes Health Status Report
Lipids.
Total Serum Cholesterol Test
Serum Triglyceride Test
Lipids & Lipoproteins Part 2.
Exp#4 Cholesterol Quantitative determination of total cholesterol in serum /plasma by enzymatic color/endpoint method.
Lipids (Lipid Profile)
Type 2 diabetes: Overlap of clinical conditions
Evolution of NCEP guidelines: ATPI - ATP III
Rational Order of Laboratory Tests in Cardiovascular Diseases
Lipids & Lipoproteins Part 2 Lecture 13.
To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?  Carl J. Lavie, MD, Richard V. Milani, MD, James.
Lipids (Lipid Profile)
Lipids (Lipid Profile)
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
Goals & Guidelines A summary of international guidelines for CHD
The test score you want to be high…
Dyslipidemia And Diabetes
National Cholesterol Education Month
Many post-MI patients are not receiving optimal therapy
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

1

2 The Good, Bad, Ugly and Deadly

3 Two Types of Lipids LIPIDS IN BLOOD TOTAL CHOLESTEROL GOOD CHOLESTEROL HDL 1 and HDL 2 BAD CHOLESTEROL LDL, VLDL (TG), Lp(a) TRIGLYCERIDES (TG)

4 Normal Lipid Profile Total Cholesterol < 200 TG ‘Ugly’ Lipid< 150 ‘Bad’ Cholesterols LDL< 100 HDL ‘Good’ cholesterol > 50 VLDL is Ugly TG ÷ 5 < 30 Lp(a) ‘Deadly’ cholesterol< 20

Normal range Element OptimalBorderlineHigh risk LDL C <100130– HDL C >6035–45<35 Triglycerides <150150–199>200 Total Choles. <200200–239>240

Cholesterol

Specimen Serum, Plasma (EDTA, Heparin) Certain anticoagulants, such as fluoride, citrate, and oxalate, cause large shifts of water from the red blood cells to the plasma, which result in the dilution of plasma components. Storage and Stability  7 days at 20 – 25 °C  7 days at 4 – 8 °C  3 months at -20 °C

Principle: Enzymatic Reaction Determination of cholesterol after enzymatic hydrolysis and oxidation. The colorimetric indicator is quinoneimine which is generated from 4-aminoantipyrine and hydroxybenzoate by hydrogen peroxide under the catalytic action of peroxidase Cholesterol Esterase Cholesterol oxidase Peroxidase

Triglycerides

Specimen Serum Plasma (EDTA) or heparin Certain anticoagulants, such as fluoride, citrate, and oxalate, cause large shifts of water from the red blood cells to the plasma, which result in the dilution of plasma components. Fasting sample (from 12 to 16 h) is essential for triglyceride analysis Storage and stability

Triglycerides Glycerol + 3 fatty acids Glycerol + ATP Glycerol-3 phosphate + ADP Glycerol-3 phosphate dihydroxyacetone + H 2 O 2 phosphate H 2 O aminophenazone+ESPA Quinoneimine Principle: Enzymatic Method Lipoprotein lipase glycerolkinase glycerolphosphate oxidase peroxidase

Triglycerides TG LevelClassificationTreatment < 150 mg%Normal TGNo Rx. 150 to 200 mg%Borderline highDiet alone 201 to 500 mg%HighDiet + drugs > 500 mg%Very highDiet + Intensive care NCEP 2004 Guidelines by expert panel on TG

HDL HDL is a fraction of plasma lipoproteins It is composed of 50% protein, 25% phospholipid, 20% cholesterol, and 5% triglycerides Evidence suggests that high-density lipoprotein (HDL) cholesterol is cardioprotective.

Testing should be postponed until after resolution of acute illness, because TGs increase and cholesterol levels decrease in inflammatory states. Lipid profiles can vary for about 30 days after an acute MI; however, results obtained within 24 h after MI are usually reliable enough to guide initial lipid-lowering therapy. LDL cholesterol values are most often calculated as the amount of cholesterol not contained in HDL and VLDL.

Discussion Interpretation of Results

How to interpret Lipid Profile Report? A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides Normal Lipid Profile

Interpret this Lipid Profile Report A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides Hyper cholesterolimia ↑LDL, HDL, TG, Lp(a) - N

A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides Hyper triglyceridemia ↑TG, HDL, LDL, Lp(a) - N Interpret this Lipid Profile Report

A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides Low HDL : ↓ HDL, LDL, TG, Lp(a) - N Interpret this Lipid Profile Report

A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides High Lipoprotein(a) : ↑ Lp(a), HDL, LDL, TG - N Interpret this Lipid Profile Report

A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides High Lipoprotein(a) : ↓ HDL, ↑ TG, LDL, Lp(a) - N Interpret this Lipid Profile Report

A.Total Cholesterol HDL Cholesterol (Soldiers) - Good Non HDL Cholesterol(Culprits) LDL Cholesterol – Bad fellows Lipoprotein(a) – Deadly fellows VLDL Cholesterol (1/5 of TG) - Ugly B.Triglycerides Combined Dyslipidemia : ↑ TC↑LDL↑TG ↑Lp(a)

Look at the risks Low HDL + High LDL + LP(a) excess > 30 mg% + LP(a) excess > 30 mg% + LDL high ++ LP(a) excess > 30 mg% + low HDL +++ LP(a) excess > 30 mg% + Incr. tHCy ++++ LP(a) excess + Incr. tHCy + low HDL Circulating lipids are one aspects Tissue lipid content is more important J. Atherosclerosis : Hopkins PN, 1997 – 17, 2792

Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes to the development of atherosclerosis. Causes may be primary (genetic) or secondary. Diagnosis is by measuring plasma levels of total cholesterol, TGs, and individual lipoproteins. Treatment is dietary changes, exercise, and lipid-lowering drugs.

Case Study #1 47 year-old man who is overweight (BMI 29) and who reports he frequently eats out, often at fast food places. What assessment tests would you recommend?

He is noted to have a blood pressure of 144/86 mmHg (average of two tests) and a fasting blood sugar of 115 mg/dl His lipid profile shows an LDL-C of 162 mg/dl and an HDL-C of 36 mg/dl, with a triglycerides of 175 mg/dl. What should the approach to treatment be and goals proposed?

Case Study #2 A 28-year old female has been diagnosed by a physician with diabetes. What assessment tests would you order?

A blood pressure of 134/82 mmHg is noted (mean of two measures) A fasting lipid profile shows an HDL-C of 40 mg/dl and LDL-C of 140 mg/dl is noted, with triglycerides of 260 mg/dl. What should the approach to treatment be?

Case Study #3 A 64-year old woman is admitted to the hospital and diagnosed with a myocardial infarction. She reports a history and has been on treatment for hypertension with. What assessments should be performed?

A fasting lipid profile done 12 hours after admission shows an LDL-C of 125 mg/dl, HDL-C of 30 mg/dl, and triglycerides of 150 mg/dl Any other recommendations for treatment?

Clinical Action For all above 20 years once in every 5 years For those above 45 yrs – once in 2 years For those with already known lipid abnormality follow-up every 3-6 months Extended Lipid profile includes Homocysteine, LP(a), SD-LDL, ALP, Apo A and Apo B, hS-CRP

There is no natural cutoff between normal and abnormal lipid levels because lipid measurements are continuous A linear relation probably exists between lipid levels and cardiovascular risk elevated TG and low HDL levels are more predictive of cardiovascular risk in women than in men HDL levels do not always predict cardiovascular risk. High HDL levels caused by some genetic disorders may not protect against cardiovascular disorders, and low HDL levels caused by some genetic disorders may not increase the risk of cardiovascular disorders.

Proof of treatment benefit is strongest for lowering elevated low-density lipoprotein (LDL) levels. In the overall population, evidence is less strong for a benefit from lowering elevated TG and increasing low high-density lipoprotein (HDL) levels, in part because elevated TG and low HDL levels are more predictive of cardiovascular risk in women than in men